These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 2537929

  • 1. Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy.
    Wagner JA, Sax FL, Weisman HF, Porterfield J, McIntosh C, Weisfeldt ML, Snyder SH, Epstein SE.
    N Engl J Med; 1989 Mar 23; 320(12):755-61. PubMed ID: 2537929
    [Abstract] [Full Text] [Related]

  • 2. Coexistence of beta-1 and beta-2 adrenergic receptors in the human heart: effects of treatment with receptor antagonists or calcium entry blockers.
    Hedberg A, Kempf F, Josephson ME, Molinoff PB.
    J Pharmacol Exp Ther; 1985 Sep 23; 234(3):561-8. PubMed ID: 2863366
    [Abstract] [Full Text] [Related]

  • 3. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
    Rasmussen RP, Minobe W, Bristow MR.
    Biochem Pharmacol; 1990 Feb 15; 39(4):691-6. PubMed ID: 2154992
    [Abstract] [Full Text] [Related]

  • 4. Hypertrophic cardiomyopathy: a desensitized cardiac beta-adrenergic system in the presence of normal plasma catecholamine concentrations.
    Schumacher C, Becker H, Conrads R, Schotten U, Pott S, Kellinghaus M, Sigmund M, Schöndube F, Preusse C, Schulte HD.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr 15; 351(4):398-407. PubMed ID: 7630430
    [Abstract] [Full Text] [Related]

  • 5. Relationship between beta-adrenoceptors and calcium channels in human ventricular myocardium.
    Ferry DR, Kaumann AJ.
    Br J Pharmacol; 1987 Mar 15; 90(3):447-57. PubMed ID: 2436700
    [Abstract] [Full Text] [Related]

  • 6. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP.
    Klin Med (Mosk); 1998 Mar 15; 76(12):30-5. PubMed ID: 10067289
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)].
    Kaltenbach M, Hopf R, Keller M.
    Dtsch Med Wochenschr; 1976 Aug 27; 101(35):1284-7. PubMed ID: 8298
    [Abstract] [Full Text] [Related]

  • 8. Hypertensive hypertrophic cardiomyopathy of the elderly.
    Topol EJ, Traill TA, Fortuin NJ.
    N Engl J Med; 1985 Jan 31; 312(5):277-83. PubMed ID: 2857050
    [Abstract] [Full Text] [Related]

  • 9. [Effects of beta-blockers and Ca antagonists on diastolic function of the hypertrophied left ventricle: an echocardiographic study].
    Isobe M, Kashida M, Isshiki T, Koizumi K, Kuwako K, Umeda T, Yamaguchi T, Machii K, Suzuki K, Tohda E.
    J Cardiogr; 1982 Dec 31; 12(4):939-52. PubMed ID: 6136549
    [Abstract] [Full Text] [Related]

  • 10. Regional expression and functional characterization of the L-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts.
    Schwinger RH, Hoischen S, Reuter H, Hullin R.
    J Mol Cell Cardiol; 1999 Jan 31; 31(1):283-96. PubMed ID: 10072735
    [Abstract] [Full Text] [Related]

  • 11. Inotropic effect of the cardioprotective agent 2,3-butanedione monoxime in failing and nonfailing human myocardium.
    Schwinger RH, Böhm M, Koch A, Morano I, Rüegg JC, Erdmann E.
    J Pharmacol Exp Ther; 1994 May 31; 269(2):778-86. PubMed ID: 8182546
    [Abstract] [Full Text] [Related]

  • 12. Autoradiographic localization and quantitation of beta 1- and beta 2-adrenoceptors in the human atrioventricular conducting system: a comparison of patients with idiopathic dilated cardiomyopathy and ischemic heart disease.
    Elnatan J, Molenaar P, Rosenfeldt FL, Summers RJ.
    J Mol Cell Cardiol; 1994 Mar 31; 26(3):313-23. PubMed ID: 7913135
    [Abstract] [Full Text] [Related]

  • 13. Myocardial beta-adrenoceptors and inhibitory G-proteins in myocardial biopsies and in explanted hearts from patients with dilated cardiomyopathy.
    Böhm M, Gierschik P, Schnabel P, Erdmann E.
    Cardioscience; 1990 Jun 31; 1(2):109-17. PubMed ID: 1966374
    [Abstract] [Full Text] [Related]

  • 14. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P, Chen L, Semmler AB, Parsonage WA, Kaumann AJ.
    Clin Exp Pharmacol Physiol; 2007 Oct 31; 34(10):1020-8. PubMed ID: 17714089
    [Abstract] [Full Text] [Related]

  • 15. [Hypertrophic obstructive cardiomyopathy: surgical treatment and results].
    Schulte HD, Lösse B.
    Herz; 1985 Apr 31; 10(2):102-11. PubMed ID: 4039290
    [Abstract] [Full Text] [Related]

  • 16. [Atrial synchronous ventricular stimulation with reduced a.v. delay time as a therapeutic principle in hypertrophic obstructive cardiomyopathy].
    Duck HJ, Hutschenreiter W, Pankau H, Trenckmann H.
    Z Gesamte Inn Med; 1984 Sep 15; 39(18):437-47. PubMed ID: 6542281
    [Abstract] [Full Text] [Related]

  • 17. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC.
    Rev Port Cardiol; 2004 Dec 15; 23(12):1557-82. PubMed ID: 15732658
    [Abstract] [Full Text] [Related]

  • 18. Hypertrophic cardiomyopathy--continued progress.
    Braunwald E.
    N Engl J Med; 1989 Mar 23; 320(12):800-2. PubMed ID: 2537930
    [No Abstract] [Full Text] [Related]

  • 19. Protective effect of clentiazem against epinephrine-induced cardiac injury in rats.
    Deisher TA, Narita H, Zera P, Ginsburg R, Bristow MR, Billingham ME, Fowler MB, Hoffman BB.
    J Pharmacol Exp Ther; 1993 Jul 23; 266(1):262-9. PubMed ID: 8392553
    [Abstract] [Full Text] [Related]

  • 20. Assessing a murmur, saving a life: current trends in the management of hypertrophic cardiomyopathy.
    Katz JR, Krafft P, Fox K.
    Nurse Pract; 1996 Nov 23; 21(11):62, 65-6, 69 passim. PubMed ID: 8933537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.